hACE2 transgenic mouse model for coronavirus (COVID-19) research
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice | Journal of Virology
Molecules | Free Full-Text | K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
Viruses | Free Full-Text | Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice
Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice | PLOS ONE
Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice | EMBO Molecular Medicine
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice | Journal of Virology
Biotechnology - hACE2 transgenic mouse, animal models for SARS-CoV-2 vaccine- or drug-development (Service provided by A4 Transgenic mouse models core facility) | National Core Facility for Biopharmaceuticals
K18-hACE2 Mice for Studies of COVID-19 Treatments and Pathogenesis Including Anosmia - Abstract - Europe PMC
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection | PNAS
Age associated susceptibility to SARS-CoV-2 infection in the K18-hACE2 transgenic mouse model | GeroScience
Mouse model of fatal COVID-19 developed for vaccine and drug testing
Kaplan-Meier curves for K18 hACE2 transgenic mice after SARS-CoV-2... | Download Scientific Diagram
A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice - eBioMedicine
Transgenic hACE2 mice for SARS-CoV-2 and COVID-19 | Taconic Biosciences
Mighty Mouse Models: Becoming Potent Weapons in the Fight Against SARS-CoV-2 | Eureka blog
COVID-19 K18-hACE2 Transgenic Mouse Model - IITRI
Protocol for infecting and monitoring susceptible k18-hACE2 mice with SARS-CoV-2 - ScienceDirect
SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy | bioRxiv
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice | Nature Communications
Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5–based COVID-19 vaccine | Science Advances
A bioengineered pseudovirus nanoparticle displaying SARS‐CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS‐CoV 2 challenge - Xia - 2023 - Biotechnology Journal - Wiley Online Library
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice | PLOS ONE
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2 - ScienceDirect
K18-hACE2 mouse (JAX™) | Animalab
